Antidepressant response associated with pioglitazone: support for an overlapping pathophysiology between major depression and metabolic syndrome.
David E
DE
Kemp
Faramarz
F
Ismail-Beigi
Joseph R
JR
Calabrese
D014150:Antipsychotic Agents / Q000627:therapeutic use*; D003865:Major Depressive Disorder / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy*; D018432:Drug Resistance, Multiple; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D024821:Metabolic Syndrome / Q000150:complications* / Q000175:diagnosis; D008875:Middle Aged; D000077205:Pioglitazone; D045162:Thiazolidinediones / Q000627:therapeutic use*
D014150:Antipsychotic Agents; D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077205:Pioglitazone